SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CECONI, Claudio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.001
AS - Asia 7.471
EU - Europa 5.401
SA - Sud America 1.396
AF - Africa 100
OC - Oceania 30
Continente sconosciuto - Info sul continente non disponibili 5
Totale 33.404
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.771
SG - Singapore 3.082
CN - Cina 2.221
IT - Italia 1.810
UA - Ucraina 1.261
BR - Brasile 1.197
HK - Hong Kong 796
DE - Germania 678
TR - Turchia 589
GB - Regno Unito 501
VN - Vietnam 338
FI - Finlandia 308
RU - Federazione Russa 276
SE - Svezia 193
MX - Messico 134
AR - Argentina 84
FR - Francia 83
ID - Indonesia 80
CA - Canada 71
IN - India 68
PL - Polonia 66
BD - Bangladesh 60
ZA - Sudafrica 44
JP - Giappone 43
AT - Austria 41
ES - Italia 40
EC - Ecuador 37
IQ - Iraq 37
NL - Olanda 35
AU - Australia 21
CO - Colombia 17
GE - Georgia 17
VE - Venezuela 17
CL - Cile 16
UZ - Uzbekistan 16
KR - Corea 15
LT - Lituania 14
MA - Marocco 13
EG - Egitto 12
PK - Pakistan 12
PY - Paraguay 12
BE - Belgio 11
CZ - Repubblica Ceca 10
KE - Kenya 10
AE - Emirati Arabi Uniti 9
IE - Irlanda 9
PE - Perù 9
AL - Albania 8
IR - Iran 8
RO - Romania 8
BG - Bulgaria 7
PH - Filippine 7
SA - Arabia Saudita 7
TN - Tunisia 7
CH - Svizzera 6
JM - Giamaica 6
JO - Giordania 6
NP - Nepal 6
NZ - Nuova Zelanda 6
PT - Portogallo 6
TW - Taiwan 6
UY - Uruguay 6
EU - Europa 5
IL - Israele 5
KG - Kirghizistan 5
LB - Libano 5
MY - Malesia 5
RS - Serbia 5
TH - Thailandia 5
BY - Bielorussia 4
HR - Croazia 4
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
CR - Costa Rica 3
GR - Grecia 3
GT - Guatemala 3
HN - Honduras 3
KZ - Kazakistan 3
MD - Moldavia 3
OM - Oman 3
PS - Palestinian Territory 3
SN - Senegal 3
TT - Trinidad e Tobago 3
AM - Armenia 2
AZ - Azerbaigian 2
HU - Ungheria 2
KH - Cambogia 2
MM - Myanmar 2
TG - Togo 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
CG - Congo 1
CI - Costa d'Avorio 1
CY - Cipro 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
Totale 33.386
Salva come PNG Salva come JPEG
Città #
Woodbridge 2.376
Fairfield 2.367
Singapore 1.669
Ashburn 1.420
Houston 1.361
Jacksonville 1.348
Seattle 990
Chandler 887
Ann Arbor 886
Wilmington 809
Cambridge 795
Hong Kong 789
Santa Clara 643
Beijing 510
Dallas 497
Izmir 432
Nanjing 410
Princeton 349
San Diego 232
Boardman 196
Milan 148
Los Angeles 142
Shenyang 135
Ho Chi Minh City 124
New York 123
Nanchang 119
Moscow 111
Rome 109
Hefei 101
Mexico City 93
São Paulo 92
Hebei 81
San Mateo 76
Changsha 75
Falls Church 68
Ferrara 68
Jiaxing 67
Tianjin 64
Warsaw 59
Jinan 58
Hanoi 57
Shanghai 57
London 55
Chicago 54
Munich 52
Naples 50
Mountain View 47
Zhengzhou 47
Verona 44
Ningbo 40
Bremen 38
Jakarta 38
Redwood City 37
Taizhou 37
Rio de Janeiro 34
The Dalles 32
Tokyo 32
Philadelphia 30
Brooklyn 29
Norwalk 27
Addison 25
Helsinki 25
Tappahannock 25
Napoli 24
Columbus 22
Guangzhou 22
Indiana 22
Johannesburg 22
Belo Horizonte 21
Hangzhou 21
Toronto 21
Falkenstein 20
Frankfurt am Main 20
Kunming 20
Stockholm 20
Brasília 19
Campinas 19
Porto Alegre 19
Turku 19
Washington 19
Des Moines 18
Guarulhos 18
Orange 18
Atlanta 17
Bari 17
Buffalo 17
Montreal 17
Nuremberg 17
Tbilisi 17
Turin 17
Goiânia 16
Lappeenranta 16
Salt Lake City 16
Tashkent 16
Bologna 15
Chennai 15
Florence 15
Haiphong 15
Salvador 15
Charlotte 14
Totale 22.467
Salva come PNG Salva come JPEG
Nome #
IL METABOLISMO DEL MIOCARDIO ISCHEMICO IBERNATO E STORDITO: DIFFERENZA TRA NECROSI E APOPTOSI 1.800
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 244
Echocardiography, Spirometry, and Systemic Acute-Phase Inflammatory Proteins in Smokers with COPD or CHF: An Observational Study 209
A way forward to the elimination of conflict of interest for experts involved in regulatory medicine and guidelines 209
2015 ESC Guidelines for the diagnosis and management of pericardial diseases The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS) 205
Chronic Obstructive Pulmonary Disease and Ischemic Heart Disease Comorbidity: Overview of Mechanisms and Clinical Management 204
ACE inhibition modulates endothelial apoptosis and renewal via endothelial progenitor cells in patients with acute coronary syndromes 201
Uric acid and coronary artery disease: An elusive link deserving further attention 199
Abnormalities of Left Ventricular Function in Asymptomatic Patients with Systemic Sclerosis Using Doppler Measures of Myocardial Strain 195
Effects of temperature on myocardial calcium homeostasis and mitochondrial function during ischemia and reperfusion 189
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC 187
Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis 186
Effect of heart rate reduction by ivabradine on left ventricular remodeling in the echocardiographic substudy of BEAUTIFUL 185
ACE inhibition modulates endothelial apoptosis and renewal via endothelial progenitor cells in patients with acute coronary syndromes (Am Journal of Cardiovasc Drugs (2011) 11:3 (189-98)) 184
A pharmacogenetic analysis of determinants of hypertension and blood pressure response to angiotensin-converting enzyme inhibitor therapy in patients with vascular disease and healthy individuals 184
Incremental exercise using progressive versus constant pedaling rates: A study in cardlac patients 183
2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation * Developed with the special contribution of the European Heart Rhythm Association. 175
The combined effect of subcutaneous granulocyte- colony stimulating factor and myocardial contrast echocardiography with intravenous infusion of sulfur hexafluoride on post-infarction left ventricular function, the RIGENERA 2.0 trial: Study protocol for a randomized controlled trial 172
Prolonged propionyl-L-carnitine pre-treatment of rabbit: Biochemical, hemodynamic and electrophysiological effects on myocardium 171
Enhanced expression and activity of xanthine oxidoreductase in the failing heart. 167
Efficacy of angiotensin-converting enzyme inhibitors in secondary prevention 164
The ACE-inhibitor Perindoprilat has high selectivity for bradykinin binding sites of human somatic ACE 161
Guidelines on myocardial revascularization 160
Link between chronic obstructive pulmonary disease and coronary artery disease: Implication for clinical practice 159
ACE inhibition with perindopril and biomarkers of atherosclerosis and thrombosis: Results from the PERTINENT study 159
Multiparametric flow cytometric characterization of circulating stem cell subsets in patients with myocardial infarction: correlation with clinical and biological data 157
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). 157
Relationship between Troponin Elevation, Cardiovascular History and Adverse Events in Patients with acute exacerbation of COPD 157
Guidelines on the management of valvular heart disease (version 2012): The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) 156
Third Universal Definition of Myocardial Infarction 155
Angiotensin-converting enzyme (ACE) inhibitors have different selectivity for bradykinin binding sites of human somatic ACE 155
Tumor necrosis factor-α receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction: The cytokine-activation and long-term prognosis in myocardial infarction (C-ALPHA) study 154
Reduction of oxidative stress by carvedilol: Role in maintenance of ischaemic myocardium viability 154
Is stunning an important component of preconditioning? 154
Non-insulin antidiabetic pharmacotherapy in patients with established cardiovascular disease: a position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy 154
Postinfarction Left Ventricular Free Wall Rupture: Original Management and Surgical Technique 153
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation 153
Time course of human atrial natriuretic factor release during cardiopulmonary bypass in mitral valve and coronary artery diseased patients 151
Specific properties and effect of perindopril in controlling the renin-angiotensin system 151
Advanced glycation end products and its soluble receptor (sRAGE) are increased in chronic heart failure but not in chronic obstructive pulmonary disease. 150
Neglected COPD and chronic comorbidities in elderly patients with chronic heart failure 147
[Angiotensin-converting enzyme inhibitors in patients with preserved left ventricular function: from EUROPA to PREAMI] 146
Occurrence of oxidative stress during reperfusion of the human heart 146
Effects of endotoxic shock on neuronal NOS and calcium transients in rat cardiac myocytes 146
Evidence against malondialdehyde bound to cellular constituents in phospholipid peroxidation 146
Effects of iloprost (ZK 36374) on glutathione status during ischaemia and reperfusion of rabbit isolated hearts 145
Myocardial damage during ischaemia and reperfusion 145
In vitro administration of ergothioneine failed to protect isolated ischaemic and reperfused rabbit heart 145
Long-term treatment with ivabradine in post-myocardial infarcted rats counteracts f-channel overexpression 145
Traditional and new composite endpoints in heart failure clinical trials: Facilitating comprehensive efficacy assessments and improving trial efficiency 145
Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery disease 145
Ischemic Heart Disease. 130 Questions & Answers 144
Effect of superoxide generation on rat heart mitochondrial pyruvate utilization 144
Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review 144
Activation of the neuroendocrine response in heart failure: adaptive or maladaptive process? 144
Bradykinin and coronary artery disease 144
[Comparative protective effect of gallopamil in myocardial ischemia and reperfusion] 144
Differences in the effect of angiotensin-converting enzyme inhibitors on the rate of endothelial cell apoptosis: in vitro and in vivo studies 143
Pathophysiological role of heart rate: from ischaemia to left ventricular dysfunction 143
Oxygen free radicals and myocardial damage: Protective role of thiol-containing agents 142
Tumor necrosis factor in congestive heart failure: a mechanism of disease for the new millennium? 142
[The double face of oxygen. An introduction to cardiac pathology caused by oxidation injury] 142
Right heart failure chronically stimulates heat shock protein 72 in heart and liver but not in other tissues. 142
Third Universal Definition of Myocardial Infarction 141
Secondary Prevention of CAD with ACE Inhibitors: A Struggle Between Life and Death of the Endothelium 141
Neuroendocrine Control of the Cardiovascular System in Heart Failure 141
Different outcomes of the reperfused myocardium: insights into the comments of stunning and hibernation. 140
The effect of propionyl-L-carnitine on the ischemic and reperfused intact myocardium and on their derived mitochondria 140
Differential action of ACE inhibitors on the eNOS pathway 140
Chromogranin A in heart failure - A novel neurohumoral factor and a predictor for mortality 140
Relevance of apoptosis in influencing recovery of hibernating myocardium 140
Plasma levels of atrial natriuretic factor and urinary excretion of arginine vasopressin and catecholamines in children with congenital heart disease effect of cardiac surgery 139
New insights on myocardial pyridine nucleotides and thiol redox state in ischemia and reperfusion damage 139
Changes in oxidative stress and cellular redox potential during myocardial storage for transplantation: Experimental studies 139
Different sites of action of diltiazem, nifedipine and verapamil on myocardial, coronary and aortic muscle 138
Selective and specific I f inhibition with ivabradine: New perspectives for the treatment of cardiovascular disease 138
Angiotensin II overproduction: enemy of the vessel wall 138
Specific and selective I-f inhibition: expected clinical benefits from pure heart rate reduction in coronary patients 138
The occurrence of oxidative stress during reperfusion in experimental animals and men 137
[Heart failure: an endothelial disorder?] 137
Efficacy of Ivabradine in Combination with Beta-Blocker Versus Uptitration of Beta-Blocker in Patients with Stable Angina 137
Oxygen Free Radicals in Shock 137
Effect of thalidomide on the skeletal muscle in experimental heart failure 137
Protective effect of propionyl-L-carnitine against ischaemia and reperfusion-damage 136
Oxygen free radicals and reperfusion injury; the effect of ischaemia and reperfusion on the cellular ability to neutralise oxygen toxicity 136
Metabolic changes during post-ischaemic reperfusion. 136
Anti-ischaemic effect of ivabradine 136
Revascularization of hibernating myocardium: Rate of metabolic and functional recovery and occurrence of oxidative stress 135
Heart rate reduction by pharmacological If current inhibition 135
Effect of ivabradine on structural and electrophysiological remodelling in a rat model of heart failure 135
ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). 135
Heart rate reduction with ivabradine prevents the global phenotype of left ventricular remodeling. 135
The influence of right heart catheterisation on pulmonary arterial pressure in chronic heart failure: relationship to neuroendocrinal changes 134
Effect of L-Carnitine derivatives on heart mitochondrial damage induced by lipid peroxidation 134
Effect of D-600 on ischemic and reperfused rabbit myocardium: relation with timing and modality of administration. 134
Metabolic adaptation during a sequence of no-flow and low-flow ischemia: A possible trigger for hibernation 133
Skeletal muscle abnormalities in rats with experimentally induced heart hypertrophy and failure 133
Oltre la dissincronia quali fattori determinano la risposta alla terapia di resincronizzazione cardiaca? 133
Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). 133
Potential prognostic significance of decreased serum levels of TRAIL after acute myocardial infarction 133
Totale 16.945
Salva come PNG Salva come JPEG
Categoria #
all - tutte 150.843
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 6.494
Totale 157.337
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.895 0 0 0 0 0 362 78 437 76 438 353 151
2021/20222.999 85 374 306 82 107 137 167 151 100 187 262 1.041
2022/20232.315 277 29 78 259 391 382 52 243 315 24 152 113
2023/20241.176 178 166 77 50 66 130 48 31 18 64 56 292
2024/20254.108 83 106 341 104 527 279 138 304 693 545 480 508
2025/20266.317 1.001 540 1.422 1.663 1.420 271 0 0 0 0 0 0
Totale 33.650